Chief Operating Officer · HERON THERAPEUTICS, INC. /DE/ · Common Stock
Side
F
Value
$2,578
Shares
8,889
Price
$0.29
Executed
Nov 6, 2026
Disclosed
Nov 10, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 10, 2026 disclosed
HRTX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$3K reported value · 4.6% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hensley Mark Earl filed this Form 4 reporting a tax withholding of HRTX on Nov 6, 2026. It became public on Nov 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Operating Officer
Hensley Mark Earlcik:0002065816
Issuer
HERON THERAPEUTICS, INC. /DE/cik:0000818033
Revision history · 0
No field has changed since this record was first ingested.
